(Q28194457)

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Screening for Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

A comparison of fecal occult-blood tests for colorectal-cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Randomised study of screening for colorectal cancer with faecal-occult-blood test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Factors associated with participation in screening for colorectal cancer with faecal occult blood testing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Cost effectiveness of colorectal cancer screening in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Cost-effectiveness model for colon cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Cost-effectiveness of screening for colorectal cancer in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Clinical practice. Screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Cost-effectiveness of colonoscopy in screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Colorectal cancer screening: clinical guidelines and rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

American Cancer Society guidelines for the early detection of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

At what age should a one-time only colonoscopy for screening of colorectal cancer be performed?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Cost-effectiveness of a single colonoscopy in screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Morphology, Anatomic Distribution and Cancer Potential of Colonic Polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Virtual colonoscopy with magnetic resonance imaging: in vitro evaluation of a new concept

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

CT colonoscopy of colorectal neoplasms: two-dimensional and three-dimensional virtual-reality techniques with colonoscopic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

The threshold approach to clinical decision making.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Diseases preceding colon cancer. A case-control study among veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

1 reference

7 January 2021

Do undesirable effects of screening affect all-cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983-1996

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2802%2900051-1

7 January 2021